Table of Contents Author Guidelines Submit a Manuscript
Infectious Diseases in Obstetrics and Gynecology
Volume 2007 (2007), Article ID 78248, 6 pages
http://dx.doi.org/10.1155/2007/78248
Research Article

Safety Study of an Antimicrobial Peptide Lactocin 160, Produced by the Vaginal Lactobacillus rhamnosus

1School of Biotechnology, The Royal Institute of Technology, Stockholm 100 44, Sweden
2Rutgers, The State University of New Jersey, New Brunswick, NJ 08901-8520, USA
3Rush Medical Center, Chicago, IL 60612, USA
4Health Promoting Naturals, Inc., Highland Park, NJ 08904, USA
5The Women's Hospital of Texas, Houston, TX 77054, USA

Received 11 October 2007; Accepted 12 November 2007

Copyright © 2007 Sara E. Dover et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. A. Aroutcheva, J. A. Simoes, and S. Faro, “Antimicrobial protein produced by Vaginal Lactobacillus acidophilus that inhibits Gardnerella vaginalis,” Infectious Diseases in Obstetrics and Gynecology, vol. 9, no. 1, pp. 33–39, 2001. View at Publisher · View at Google Scholar
  2. J. Li, A. A. Aroutcheva, S. Faro, and M. L. Chikindas, “Mode of action of lactocin 160, a bacteriocin from vaginal Lactobacillus rhamnosus,” Infectious Diseases in Obstetrics and Gynecology, vol. 13, no. 3, pp. 135–140, 2005. View at Publisher · View at Google Scholar
  3. G. B. Hill, “The microbiology of bacterial vaginosis,” American Journal of Obstetrics and Gynecology, vol. 169, no. 2, part 2, pp. 450–454, 1993. View at Google Scholar
  4. S. L. Hillier, R. P. Nugent, D. A. Eschenbach et al., “Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant,” The New England Journal of Medicine, vol. 333, no. 26, pp. 1737–1742, 1995. View at Publisher · View at Google Scholar
  5. C. A. Flynn, A. L. Helwig, and L. N. Meurer, “Bacterial vaginosis in pregnancy and the risk of prematurity: a meta-analysis,” The Journal of Family Practice, vol. 48, no. 11, pp. 885–892, 1999. View at Google Scholar
  6. H. L. Martin Jr., B. A. Richardson, P. M. Nyange et al., “Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition,” Journal of Infectious Diseases, vol. 180, no. 6, pp. 1863–1868, 1999. View at Publisher · View at Google Scholar
  7. S. Ayehunie, C. Cannon, S. Lamore et al., “Organotypic human vaginal-ectocervical tissue model for irritation studies of spermicides, microbicides, and feminine-care products,” Toxicology in Vitro, vol. 20, no. 5, pp. 689–698, 2006. View at Publisher · View at Google Scholar
  8. A. M. Geshnizgani and A. B. Onderdonk, “Defined medium simulating genital tract secretions for growth of vaginal microflora,” Journal of Clinical Microbiology, vol. 30, no. 5, pp. 1323–1326, 1992. View at Google Scholar
  9. J. E. Davis, J. H. Frudenfeld, and J. L. Goddard, “Comparative evaluation of Monistat and Mycostatin in the treatment of vulvovaginal candidiasis,” Obstetrics & Gynecology, vol. 44, no. 3, pp. 403–406, 1974. View at Google Scholar
  10. P. R. Sawyer, R. N. Brogden, R. M. Pinder, T. M. Speight, and G. S. Avery, “Miconazole: a review of its antifungal activity and therapeutic efficacy,” Drugs, vol. 9, no. 6, pp. 406–423, 1975. View at Google Scholar
  11. E. Ozyurt, M. B. Toykuliyeva, I. L. Danilyans, O. Morton, and G. Baktir, “Efficacy of 7-day treatment with metronidazole+miconazole (Neo-Penotran®)-a triple-active pessary for the treatment of single and mixed vaginal infections,” International Journal of Gynecology & Obstetrics, vol. 74, no. 1, pp. 35–43, 2001. View at Publisher · View at Google Scholar
  12. T. Mosmann, “Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays,” Journal of Immunological Methods, vol. 65, no. 1-2, pp. 55–63, 1983. View at Publisher · View at Google Scholar
  13. R. Hertle, S. Brutsche, W. Groeger et al., “Specific phosphatidylethanolamine dependence of Serratia marcescens cytotoxin activity,” Molecular Microbiology, vol. 26, no. 5, pp. 853–865, 1997. View at Publisher · View at Google Scholar
  14. S. Niruthisard, R. E. Roddy, and S. Chutivongse, “The effects of frequent nonoxynol-9 use on the vaginal and cervical mucosa,” Sexually Transmitted Diseases, vol. 18, no. 3, pp. 176–179, 1991. View at Google Scholar
  15. I. F. Hoffman, T. E. Taha, N. S. Padian et al., “Nonoxynol-9 100?mg gel: multi-site safety study from sub-Saharan Africa,” AIDS, vol. 18, no. 16, pp. 2191–2195, 2004. View at Publisher · View at Google Scholar
  16. P. Eckstein, M. C. Jackson, N. Millman, and A. J. Sobrero, “Comparison of vaginal tolerance tests of spermicidal preparations in rabbits and monkeys,” Journal of Reproduction and Fertility, vol. 20, no. 1, pp. 85–93, 1969. View at Publisher · View at Google Scholar
  17. L. J. Zaneveld, D. P. Waller, R. A. Anderson et al., “Efficacy and safety of a new vaginal contraceptive antimicrobial formulation containing high molecular weight poly(sodium 4-styrenesulfonate),” Biology of Reproduction, vol. 66, no. 4, pp. 886–894, 2002. View at Google Scholar
  18. O. J. D'Cruz, B. Waurzyniak, and F. M. Uckun, “Mucosal toxicity studies of a gel formulation of native pokeweed antiviral protein,” Toxicologic Pathology, vol. 32, no. 2, pp. 212–221, 2004. View at Publisher · View at Google Scholar
  19. M. M. Dhondt, E. Adriaens, J. V. Roey, and J. P. Remon, “The evaluation of the local tolerance of vaginal formulations containing dapivirine using the Slug Mucosal Irritation test and the rabbit vaginal irritation test,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 60, no. 3, pp. 419–425, 2005. View at Publisher · View at Google Scholar
  20. G. F. Doncel, N. Chandra, and R. N. Fichorova, “Preclinical assessment of the proinflammatory potential of microbicide candidates,” Journal of Acquired Immune Deficiency Syndromes, vol. 37, supplement, pp. S174–S180, 2004. View at Google Scholar
  21. L. Van Damme, G. Ramjee, M. Alary et al., “Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial,” The Lancet, vol. 360, no. 9338, pp. 971–977, 2002. View at Publisher · View at Google Scholar
  22. M. Chvapil, W. Droegemueller, J. A. Owen, C. D. Eskelson, and K. Betts, “Studies of nonoxynol-9. I. The effect on the vaginas of rabbits and rats,” Fertility and Sterility, vol. 33, no. 4, pp. 445–450, 1980. View at Google Scholar
  23. K. V. R. Reddy, C. Aranha, S. M. Gupta, and R. D. Yedery, “Evaluation of antimicrobial peptide nisin as a safe vaginal contraceptive agent in rabbits: in vitro and in vivo studies,” Reproduction, vol. 128, no. 1, pp. 117–126, 2004. View at Publisher · View at Google Scholar
  24. F. C. Krebs, S. R. Miller, B. J. Catalone et al., “Sodium dodecyl sulfate and C31G as microbicidal alternatives to nonoxynol 9: comparative sensitivity of primary human vaginal keratinocytes,” Antimicrobial Agents and Chemotherapy, vol. 44, no. 7, pp. 1954–1960, 2000. View at Publisher · View at Google Scholar
  25. F. C. Krebs, S. R. Miller, B. J. Catalone et al., “Comparative in vitro sensitivities of human immune cell lines, vaginal and cervical epithelial cell lines, and primary cells to candidate microbicides nonoxynol 9, C31G, and sodium dodecyl sulfate,” Antimicrobial Agents and Chemotherapy, vol. 46, no. 7, pp. 2292–2298, 2002. View at Publisher · View at Google Scholar
  26. R. N. Fichorova, M. Bajpai, N. Chandra et al., “Interleukin (IL)-1, IL-6 and IL-8 predict mucosal toxicity of vaginal microbicidal contraceptives,” Biology of Reproduction, vol. 71, no. 3, pp. 761–769, 2004. View at Publisher · View at Google Scholar
  27. J. Cleveland, T. J. Montville, I. F. Nes, and M. L. Chikindas, “Bacteriocins: safe, natural antimicrobials for food preservation,” International Journal of Food Microbiology, vol. 71, no. 1, pp. 1–20, 2001. View at Publisher · View at Google Scholar
  28. C. Aranha, S. Gupta, and K. V. R. Reddy, “Contraceptive efficacy of antimicrobial peptide Nisin: in vitro and in vivo studies,” Contraception, vol. 69, no. 4, pp. 333–338, 2004. View at Publisher · View at Google Scholar
  29. S. Maher and S. McClean, “Investigation of the cytotoxicity of eukaryotic and prokaryotic antimicrobial peptides in intestinal epithelial cells in vitro,” Biochemical Pharmacology, vol. 71, no. 9, pp. 1289–1298, 2006. View at Publisher · View at Google Scholar
  30. J. A. McGroarty, L. Tomeczek, D. G. Pond, G. Reid, and A. W. Bruce, “Hydrogen peroxide production by Lactobacillus species: correlation with susceptibility to the spermicidal compound nonoxynol-9,” Journal of Infectious Diseases, vol. 165, no. 6, pp. 1142–1144, 1992. View at Google Scholar
  31. M. K. Stafford, H. Ward, A. Flanagan et al., “Safety study of nonoxynol-9 as a vaginal microbicide: evidence of adverse effects,” Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, vol. 17, no. 4, pp. 327–331, 1998. View at Google Scholar
  32. L. M. Pascual, M. B. Daniele, C. Pájaro, and L. Barberis, “Lactobacillus species isolated from the vagina: identification, hydrogen peroxide production and nonoxynol-9 resistance,” Contraception, vol. 73, no. 1, pp. 78–81, 2006. View at Publisher · View at Google Scholar